🔊Catch us at Buffalo Fireside Chats in 5 minutes! $CVAT

🎙️Check out the update from our CEO Neil Voloshin $CVAT

🎙 The first episode of our podcast Tech After Tomorrow! $CVAT #XYRA 📎 youtube.com/watch?v=Xf3ojZ… Anton Glotser talks with Ricardo Aguilar, a tech entrepreneur from Honduras, about the region’s tech scene, fintech growth, and new business opportunities in Central America.

🇺🇸 JUST IN: The Federal Reserve is studying a new “payment account” model that would give fintech and crypto firms limited access to Fed payment rails without full banking privileges.

🎙️FinTech. AI. Remittances. #XYRA #CVAT youtube.com/watch?v=Xf3ojZ…

Shares Of Quantum Computing Firms Surge After Reports Trump Administration Could Take A Stake go.forbes.com/8KPmvV

XYRA Corp. Targets the Gap Between Mexico’s $65B Fintech Market and Cross-Border Remittance Flows globenewswire.com/NewsRoom/Relea…

📰 $CVAT #XYRA is developing the first AI-driven, #quantum-secure payment infrastructure that unites remittances and fintech through tokenization, delivering a seamless, compliant, and future-proof financial layer for the global economy. globenewswire.com/news-release/2…

📰 $CVAT #XYRA is the first to connect cross-border remittances directly with credit card issuance. globenewswire.com/news-release/2…

📰 $CVAT #XYRA unites remittances and fintech through AI-driven tokenization to deliver the first quantum-secure payment layer for the global economy. globenewswire.com/news-release/2…

Working on multiple sides of the $CVAT business. Big plans ahead in #OilAndGas 🚀otcmarkets.com/stock/CVAT/ove…

🎙️Enormous opportunities for #remittances across Central & South America $CVAT #XYRA youtube.com/watch?v=Xf3ojZ…

💡Be the first to know — join the $CVAT NEWSLETTER 👇 cvatinfo.com

Blockchain isn’t bulletproof if it’s not #quantum-ready. That’s why #XYRA puts security of payments first $CVAT #FinTech #Remittances

cvatinfo.com 😎 $CVAT

Monday is here 🔥 otcmarkets.com/stock/CVAT/ove…

🌍 NDA signed with German & Spanish companies for $CVAT #Plasma water treatment. Active discussions this week.